Empagliflozin Efficacy and Mineralocorticoid Receptor Antagonists in Patients With HF
Researchers sought to compare the effect of empagliflozin in patients that do vs patients that do not take mineralocorticoid receptor antagonists for HFpEF.
Researchers sought to compare the effect of empagliflozin in patients that do vs patients that do not take mineralocorticoid receptor antagonists for HFpEF.
Researchers sought to determine the efficacy and safety of percutaneous transluminal pulmonary angioplasty for Takayasu arteritis-associated pulmonary HTN.
A study was conducted to determine the prognostic value of hyponatremia and its effect on the effectiveness of dapagliflozin in patients hospitalized for HFrEF.
The AHA has issued a scientific statement regarding cardiovascular manifestations and complications in children who have had SARS-CoV-2.
Investigators compared the efficacy and safety of catheter ablation and antiarrhymatic medication as first-line therapy for patients with an ICD and ventricular tachycardia.
A prospective cohort study was conducted to determine the relationship between multiple modifiable lifestyle factors and risk for peripheral artery disease.
The American College of Cardiology has issued a policy statement regarding civility, inclusion, and respect in the cardiovascular workplace.
The American Heart Association has issued a scientific statement regarding the relationship between nonalcoholic fatty liver disease and cardiovascular risk.
A study was conducted to determine the efficacy and safety of dapagliflozin in HFrEF patients in Asia compared with other patient populations.
The aim of the study was to evaluate the prevalence of chronic pain disparities among the major racial and ethnic groups in the US.